Generation of three heterozygous KCNH2 mutation-carrying human induced pluripotent stem cell lines for modeling LQT2 syndrome

Generation of three heterozygous KCNH2 mutation-carrying human induced pluripotent stem cell lines for modeling LQT2 syndrome

Congenital long QT syndrome type 2 (LQT2) results from KCNH2 mutations that cause loss of Kv11.1 channel function which can lead to arrhythmias, syncope, and sudden death. Here, we generated three human-induced pluripotent stem cell (iPSC) lines from peripheral blood mononuclear cells (PBMCs) of two...

Full description

Bibliographic Details
Main Authors:	Gema Mondéjar-Parreño, James W.S. Jahng, Nadjet Belbachir, Blake C. Wu, Xiaolan Zhang, Marco V. Perez, Nitish Badhwar, Joseph C. Wu
Format:	Article
Language:	English
Published:	Elsevier 2021-07-01
Series:	Stem Cell Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S1873506121002488

Similar Items

Generation of induced pluripotent stem cell lines from patients with LQT1 caused by heterozygous mutations in the KCNQ1 gene
by: Lu Ren, et al.
Published: (2024-08-01)

Generation of human induced pluripotent stem cell lines carrying heterozygous PLN mutation from dilated cardiomyopathy patients
by: Arianne Caudal, et al.
Published: (2022-08-01)

Generation of three induced pluripotent stem cell lines (SCVIi014-A, SCVIi015-A, and SCVIi016-A) from patients with LQT1 caused by heterozygous mutations in the KCNQ1 gene
by: Hao Zhang, et al.
Published: (2021-08-01)

Generation of KCNH2 heterozygous knockout induced pluripotent stem cell (iPSC) line (Long and Short QT Syndrome)
by: Baiqiang Wang, et al.
Published: (2024-06-01)

Aborted Cardiac Arrest in LQT2 Related to Novel <i>KCNH2</i> (<i>hERG</i>) Variant Identified in One Lithuanian Family
by: Neringa Bileišienė, et al.
Published: (2021-07-01)

Age and gender related differences in corrected QT interval in children and adolescents with LQT1 and LQT2
by: Vink, A, et al.
Published: (2016)

Generation and characterization of an induced pluripotent stem cell (iPSC) line (NUIGi003-A) from a long QT syndrome type 2 (LQT2) patient harbouring the KCNH2 c.2464G>A pathogenic variant
by: Ning Ge, et al.
Published: (2020-12-01)

Generation of two induced pluripotent stem cell lines from catecholaminergic polymorphic ventricular tachycardia patients carrying RYR2 mutations
by: Xiaohui Kong, et al.
Published: (2023-06-01)

Generation of an induced pluripotent stem cell line from a long QT syndrome patient carrying KCNH2/1956C > A mutation
by: Fengfeng Guo, et al.
Published: (2022-07-01)

Generation of induced pluripotent stem cells (iPSCs) from a Chinese infant (XACHi015-A) with type 2 Long QT syndrome carrying the heterozygous mutation c.1814C>T(p.P605L) in KCNH2
by: Tao Wang, et al.
Published: (2021-10-01)

Unraveling the Role of K2P Channels in Atrial Fibrillation
by: Gema Mondéjar-Parreño
Published: (2022-11-01)

Generation of two induced pluripotent stem cell lines from Brugada syndrome affected patients carrying SCN5A mutations
by: Nadjet Belbachir, et al.
Published: (2021-12-01)

Establishment of human embryonic stem cell lines carrying LQT1 mutations by CRISPR base editing
by: Xiaoman Wang, et al.
Published: (2024-09-01)

Eag Domains Regulate LQT Mutant hERG Channels in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
by: Qiang-Ni Liu, et al.
Published: (2015-01-01)

The lack of effect of sotalol in short QT syndrome patients carrying the T618I mutation in the KCNH2 gene
by: Carla Giustetto, MD, et al.
Published: (2015-09-01)

Generation of three induced pluripotent stem cell lines from hypertrophic cardiomyopathy patients carrying MYH7 mutations
by: Xu Cao, et al.
Published: (2021-08-01)

Establishment of human embryonic stem cell WAe009-A-88 carrying a long QT syndrome mutation in KCNH2
by: Hong Wen, et al.
Published: (2022-07-01)

Human induced pluripotent stem cell line ZZUNEUi027-A generated from a long QT syndrome patient with a heterozygous KCNH2 (c. 128 A > G) mutant
by: Jiangtao Zhao, et al.
Published: (2022-08-01)

Establishment of human embryonic stem cell WAe009-A-74 carrying a Long QT syndrome mutation in KCNH2
by: Lixiang Sun, et al.
Published: (2022-04-01)

Generation of two heterozygous MYBPC3 mutation-carrying human iPSC lines, SCVIi001-A and SCVIi002-A, for modeling hypertrophic cardiomyopathy
by: Lichao Liu, et al.
Published: (2021-05-01)

Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients carrying heterozygous FLNC mutations
by: Ana Kojic, et al.
Published: (2022-10-01)

KCNH2 regulates the growth and metastasis of pancreatic cancer
by: Jinghao Lei, et al.
Published: (2023-09-01)

Protective effect of <it>KCNH2 </it>single nucleotide polymorphism K897T in LQTS families and identification of novel <it>KCNQ1 </it>and <it>KCNH2 </it>mutations
by: Oberti Carlos, et al.
Published: (2008-09-01)

Generation of three induced pluripotent stem cell lines, SCVIi003-A, SCVIi004-A, SCVIi005-A, from patients with ARVD/C caused by heterozygous mutations in the PKP2 gene
by: James W.S. Jahng, et al.
Published: (2021-05-01)

Establishment of induced pluripotent stem cell lines from an ARVC patient carrying a heterozygous variant in LAMA2 gene
by: Yue Wang, et al.
Published: (2023-02-01)

Designing an Optimal Control LQT for Controlling and Guidance of Missile
by: Rusdhianto Effendie AK, et al.
Published: (2018-05-01)

Generation of two induced pluripotent stem cell lines from patients with cardiac amyloidosis carrying heterozygous transthyretin (TTR) mutation
by: Bernardo Bonilauri, et al.
Published: (2023-10-01)

Association between polymorphisms in NOS3 and KCNH2 and social memory
by: Susanne eHenningsson, et al.
Published: (2015-10-01)

Generation of patient-specific induced pluripotent stem cell lines with Type 2 Long QT Syndrome and the KCNH2 c.379C > T pathogenic variant
by: Lamia Goual, et al.
Published: (2023-10-01)

Generation of a human embryonic stem cell line (WAe009-A-43) carrying a Long QT syndrome related mutation in KCNH2 gene
by: Xiaodan Wu, et al.
Published: (2020-10-01)

Generation of two induced pluripotent stem cell lines from hereditary amyloidosis patients with polyneuropathy carrying heterozygous transthyretin (TTR) mutation
by: Juan Melesio, et al.
Published: (2024-02-01)

Derivation and characterization of two human induced pluripotent stem cell lines (NUIGi004-A) and (NUIGi012-A) from two patients with LQT2 disease
by: Min Liu, et al.
Published: (2021-10-01)

Phenotypic variability in LQT3 human induced pluripotent stem cell-derived cardiomyocytes and their response to antiarrhythmic pharmacologic therapy: An in silico approach
by: Paci, M, et al.
Published: (2017)

Integration of validated functional evidence to support the pathogenicity of KCNH2 variants
by: Reema W. Aljassar, et al.
Published: (2024-01-01)

Torsades de Pointes electrical storm in children with KCNH2 mutations
by: Li Zhang, et al.
Published: (2024-10-01)

Establishment of a human-induced pluripotent stem cell line from a long QT syndrome type 2 patient harboring a KCNH2 mutation
by: Dasom Mun, et al.
Published: (2024-12-01)

An LQT2-related mutation in the voltage-sensing domain is involved in switching the gating polarity of hERG
by: Zhipei Liu, et al.
Published: (2024-02-01)

Changes in channel trafficking and protein stability caused by LQT2 mutations in the PAS domain of the HERG channel.
by: Carol A Harley, et al.
Published: (2012-01-01)

Establishment of a human induced pluripotent stem cell line (ABi004-A) carrying a compound heterozygous mutation in the KCNV2 gene
by: Almaqdad Alsalloum, et al.
Published: (2024-10-01)

Defining candidate drug characteristics for Long-QT (LQT3) syndrome
by: Aslak Tveito, et al.
Published: (2011-05-01)